Anlotinib Inhibiting Mantle Cell Lymphoma Proliferation and Inducing Apoptosis through PI3K/AKT/mTOR Pathway

Jiaping Wang; Zhijuan Xu; Yanli Lai; Yanli Zhang; Ping Zhang; Qitian Mu; Shujun Yang; Lixia Sheng; Guifang Ouyang

doi:10.2174/0115665240284638240408081133

Related publications

Article2023

Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma

Núria Profitós-Pelejà, Marcelo Lima Ribeiro, J. Parra, Miranda Fernández-Serrano, Pau Marin-Escudero, Adar Makovski-Silverstein, Stephen C. Cosenza, Manel Esteller, Gaël Roué

Article2006

Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy

Sílvia Marcé, Olga Balagué, Luís Colomo, Antonio Martı́nez, Sylvia Höller, Neus Villamor, Francesc Bosch, German Ott, Andreas Rosenwald, Lorenzo M. Leoni, Manel Esteller, Mario F. Fraga, Emili Montserrat, Dolors Colomer, Elı́as Campo

Preprint2022

Fangchinoline derivatives inhibits PI3K signaling in vivo and in vitro in non-small cell lung cancer

Jia‐Shu Chen, Xu Guo, Mu-xuan Wang, Xiu-zheng Gao, Jinlong Han, Jinyue Sun, Ningyang Li, Jesus Simal Gandara, Chao Liu

Article2019

Abstract 4725: Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia

Lorea Villanueva, Montserrat Pérez-Salvia, Eneko Aldaba, Yosu Vara, Myriam Fabre, Cristina Suárez Ferrer, Carme Masdeu, Aizpea Zubia, Eider San Sebastián, Dorleta Otaegui, Pere Llinàs‐Arias, Margalida Rosselló-Tortella, María Berdasco, Fernando Setién, Cátia Moutinho, Alberto Villanueva, Eva González‐Barca, Josep Muncunill, José‐Tomás Navarro, Miguel Á. Piris, Fernando P. Cossío, Manel Esteller

Article2019

Abstract 4725: Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia

Lorea Villanueva, Montserrat Pérez-Salvia, Eneko Aldaba, Y. Vara, Myriam Fabre, Cristina Suárez Ferrer, Carme Masdeu, Aizpea Zubia, Eider San Sebastián, Dorleta Otaegui, Pere Llinàs‐Arias, Margalida Rosselló-Tortella, María Berdasco, Fernando Setién, Cátia Moutinho, Alberto Villanueva, Eva González‐Barca, Josep Muncunill, José‐Tomás Navarro, Miguel Á. Piris, Fernando P. Cossío, Manel Esteller

Anlotinib Inhibiting Mantle Cell Lymphoma Proliferation and Inducing Apoptosis through PI3K/AKT/mTOR Pathway

Abstract

Discussion(0)

Related publications

Prolonged cell cycle arrest by the CDK4/6 antagonist narazaciclib restores ibrutinib response in preclinical models of BTKi‐resistant mantle cell lymphoma

Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy

Fangchinoline derivatives inhibits PI3K signaling in vivo and in vitro in non-small cell lung cancer

Abstract 4725: Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia

Abstract 4725: Efficacy of a new small-molecule inhibitor of histone deacetylase 6 (HDAC6) in preclinical models of B-cell lymphoma and acute myeloid leukemia